Last checked at 30 Jul 2021 16:05
UK earnings, trading statements calendar - next 7 days
UK earnings, trading statements calendar - next 7 days
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Hikma Pharmaceuticals Share News (HIK)
HIK Share
Price
HIK Share
News
HIK Share
Chat
HIK Share
Trades578
HIK
Live RNS
HIK Share
Charts
HIK Level 2
Console
HIK Live
Share Price
HIK Broker
Ratings
HIK Directors
Deals
HIK Financial
Diary
HIK
Fundamentals
HIK Short
Positions
HIK
Media
Hikma Pharmaceuticals Information
Share Price Information for Hikma Pharmaceuticals (HIK)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1,775.00
Bid:
1,774.00
Ask:
1,776.00
Change:
-14.00 (-0.78%)
Spread:
2.00 (0.113%)
Open:
1,786.00
High:
1,786.00
Low:
1,763.00
Prev. Close:
1,789.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.14 Jul 2021 19:38
IN BRIEF: Arecor ends first half of 2021 with solid cash position
IN BRIEF: Arecor ends first half of 2021 with solid cash position
Read more13 Jul 2021 10:00
BROKER RATINGS: Barclays upgrades Shell and EnQuest to Overweight
BROKER RATINGS: Barclays upgrades Shell and EnQuest to Overweight
Read more1 Jul 2021 09:51
BROKER RATINGS: Credit Suisse upgrades Legal & General and StanChart
BROKER RATINGS: Credit Suisse upgrades Legal & General and StanChart
Read more21 Jun 2021 14:51
UPDATE 1-U.S. Supreme Court denies Amarin's bid to revive Vascepa drug patents
(Adds background to case, paragraphs 4-10)By Blake BrittainWASHINGTON, June 21 (Reuters) - The U.S. Supreme Court on Monday rejected a bid by an Amarin Corp PLC subsidiary to revive patents on its heart drug Vascepa in a legal battle against gener...
Read more21 Jun 2021 14:31
U.S. Supreme Court denies Amarin's bid to revive Vascepa drug patents
WASHINGTON, June 21 (Reuters) - The U.S. Supreme Court on Monday rejected a bid by an Amarin Corp PLC subsidiary to revive patents on its heart drug Vascepa in a legal battle against generic drugmakers Hikma Pharmaceuticals PLC and Dr. Reddy's La...
Read more8 Jun 2021 13:54
Tuesday broker round-up
(Sharecast News) - tinyBuild: Berenberg reiterates buy with a target price of 295p.
Read more6 May 2021 09:46
BROKER RATINGS: Exane BNP downgrades three property companies
BROKER RATINGS: Exane BNP downgrades three property companies
Read more30 Apr 2021 17:01
LONDON MARKET CLOSE: Stocks close out impressive April to end higher
LONDON MARKET CLOSE: Stocks close out impressive April to end higher
Read more30 Apr 2021 08:58
TOP NEWS: Hikma Pharma confident after promising start to year
TOP NEWS: Hikma Pharma confident after promising start to year
Read more30 Apr 2021 07:57
LONDON MARKET PRE-OPEN: Barclays, AstraZeneca post sharp profit rises
LONDON MARKET PRE-OPEN: Barclays, AstraZeneca post sharp profit rises
Read more30 Apr 2021 07:38
Hikma predicts generics revenue at top of guidance
(Sharecast News) - Hikma Pharmaceutical said it made a good start to 2021 and that annual revenue from generic treatments would be at the top of guidance.
Read more23 Apr 2021 16:01
UK earnings, trading statements calendar - next 7 days
UK earnings, trading statements calendar - next 7 days
Read more21 Apr 2021 12:08
LONDON MARKET MIDDAY: Stocks recover modestly; Netflix misses targets
LONDON MARKET MIDDAY: Stocks recover modestly; Netflix misses targets
Read more21 Apr 2021 10:06
Hikma resumes asthma drug launch, Vectura pays special dividend
Hikma resumes asthma drug launch, Vectura pays special dividend
Read more